{
    "2020-10-01": [
        [
            {
                "time": "2020-10-01",
                "original_text": "After Hours Most Active for Oct 1, 2020: VICI, AAPL, SLB, ABBV, SGMS, MSFT, HST, MNST, APA, RUN, GE, VZ",
                "features": {
                    "keywords": [
                        "Most Active",
                        "VICI",
                        "AAPL",
                        "ABBV",
                        "MSFT"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-01",
                "original_text": "Best ETFs for 2020: The AdvisorShares Vice ETF Saved by SAM and TMO",
                "features": {
                    "keywords": [
                        "ETFs",
                        "AdvisorShares",
                        "Vice",
                        "SAM",
                        "TMO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "financial products"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-01",
                "original_text": "Stocks Are Expensive. These 14 Are Cheap and Could Grow.",
                "features": {
                    "keywords": [
                        "Expensive",
                        "Cheap",
                        "Grow"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-01",
                "original_text": "Cramer Gives His Opinion On AbbVie, Snowflake And More",
                "features": {
                    "keywords": [
                        "Cramer",
                        "Opinion",
                        "AbbVie",
                        "Snowflake"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-01",
                "original_text": "7 Dividend Stocks Perfect for a Retireeâ€™s Portfolio",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Stocks",
                        "Retiree",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "income stocks"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-01",
                "original_text": "AbbVie: New Brunswick, British Columbia List SKYRIZI On Its Provincial Formulary",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "SKYRIZI",
                        "Provincial Formulary"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}